The federal government is intervening in a whistleblower lawsuit accusing St. Jude Medical Inc. (NYSE:STJ) of using four post-market clinical trials as "kickback vehicles."
In a motion to intervene filed August 5 in the U.S. District Court for Massachusetts, the U.S. claimed it has "good cause" to accuse the St. Paul, Minn.-based company of using its Aware, Assist, Housecall Plus and Act registry trials as fronts to deliver kickbacks to doctors in return for their use of its pacemakers and defibrillators.